{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:52:32Z","timestamp":1763347952767},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T00:00:00Z","timestamp":1426032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s11060-015-1754-9","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T09:46:36Z","timestamp":1425980796000},"page":"491-496","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Decreased tumor apparent diffusion coefficient correlates with objective response of pediatric low-grade glioma to bevacizumab"],"prefix":"10.1007","volume":"122","author":[{"given":"Christopher H.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Lober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Partap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick D.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen W.","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,11]]},"reference":[{"issue":"Suppl 5","key":"1754_CR1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","volume":"14","author":"TA Dolecek","year":"2012","unstructured":"Dolecek TA, Propp JM, Stroup NE et al (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009. Neuro Oncol 14(Suppl 5):v1\u2013v49","journal-title":"Neuro Oncol"},{"key":"1754_CR2","first-page":"149","volume":"65","author":"RM Lober","year":"2013","unstructured":"Lober RM (2013) Low grade gliomas of childhood: the actual management. Minerva Pediatr 65:149\u2013165","journal-title":"Minerva Pediatr"},{"key":"1754_CR3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/pbc.21935","volume":"52","author":"RJ Packer","year":"2009","unstructured":"Packer RJ, Jakacki R, Horn M et al (2009) Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan. Pediatr Blood Cancer 52:791\u2013795","journal-title":"Pediatr Blood Cancer"},{"key":"1754_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/pbc.24066","volume":"59","author":"ML Couec","year":"2012","unstructured":"Couec ML, Andre N, Thebaud E et al (2012) Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trends. Pediatr Blood Cancer 59:34\u201338","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1754_CR5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/neuonc\/not154","volume":"16","author":"S Gururangan","year":"2014","unstructured":"Gururangan S, Fangusaro J, Poussaint TY et al (2014) Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas\u2014a pediatric brain tumor consortium study. Neuro Oncol 16(2):310\u2013317","journal-title":"Neuro Oncol"},{"key":"1754_CR6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24297","volume":"60","author":"EI Hwang","year":"2013","unstructured":"Hwang EI, Jakacki RI, Fisher MJ et al (2013) Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatr Blood Cancer 60:776\u2013782","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"1754_CR7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/neuonc\/noq206","volume":"13","author":"BM Ellingson","year":"2011","unstructured":"Ellingson BM, Cloughesy TF, Lai A et al (2011) Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13(4):401\u2013409","journal-title":"Neuro Oncol"},{"issue":"1","key":"1754_CR8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1522-2594(199901)41:1<2::AID-MRM2>3.0.CO;2-Y","volume":"41","author":"RK Gupta","year":"1999","unstructured":"Gupta RK, Sinha U, Cloughesy TF et al (1999) Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med 41(1):2\u20137","journal-title":"Magn Reson Med"},{"key":"1754_CR9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2214\/ajr.162.3.8109520","volume":"162","author":"RD Tien","year":"1994","unstructured":"Tien RD, Felsberg GJ, Friedman H et al (1994) MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echo planar pulse sequences. Am J Roentgen 162:671\u2013677","journal-title":"Am J Roentgen"},{"issue":"2","key":"1754_CR10","first-page":"361","volume":"16","author":"JA Brunberg","year":"1995","unstructured":"Brunberg JA, Chenevert TL, McKeever PE et al (1995) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. Am J Neuroradiol 16(2):361\u2013371","journal-title":"Am J Neuroradiol"},{"issue":"1","key":"1754_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2","volume":"9","author":"T Sugahara","year":"1999","unstructured":"Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9(1):53\u201360","journal-title":"J Magn Reson Imaging"},{"key":"1754_CR12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2214\/ajr.177.2.1770449","volume":"177","author":"KM Gauvain","year":"2001","unstructured":"Gauvain KM, McKinstry RC, Mukherjee RC et al (2001) Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. Am J Roentgen 177:449\u2013454","journal-title":"Am J Roentgen"},{"issue":"5","key":"1754_CR13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3174\/ajnr.A3333","volume":"34","author":"KW Yeom","year":"2013","unstructured":"Yeom KW, Lober RM, Mobley BC et al (2013) Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma. Am J Neuroradiol 34(5):1056\u20131061","journal-title":"Am J Neuroradiol"},{"key":"1754_CR14","first-page":"1457","volume":"3","author":"TL Chenevert","year":"1997","unstructured":"Chenevert TL, McKeever PE, Ross BD (1997) Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3:1457\u20131466","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1754_CR15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11060-013-1140-4","volume":"113","author":"KW Yeom","year":"2013","unstructured":"Yeom KW, Lober RM, Andre JB et al (2013) Prognostic role for diffusion-weighted imaging of pediatric optic pathway glioma. J Neurooncol 113(3):479\u2013483","journal-title":"J Neurooncol"},{"key":"1754_CR16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11060-009-9981-6","volume":"96","author":"R Jain","year":"2010","unstructured":"Jain R, Scarpas LM, Shehanaz E et al (2010) Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as a biomarker. J Neurooncol 96:423\u2013431","journal-title":"J Neurooncol"},{"key":"1754_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11060-013-1072-z","volume":"112","author":"EJ Hwang","year":"2013","unstructured":"Hwang EJ, Cha Y, Lee AL et al (2013) Early response evaluation for recurrent high grade gliomas treated with bevacizumab: a volumetric analysis using diffusion-weighted imaging. J Neurooncol 112:427\u2013435","journal-title":"J Neurooncol"},{"issue":"4","key":"1754_CR18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2214\/AJR.12.9249","volume":"200","author":"KW Yeom","year":"2013","unstructured":"Yeom KW, Mobley BC, Lober RM et al (2013) Distinctive MRI features of pediatric medulloblastoma subtypes. Am J Roentgenol 200(4):895\u2013903","journal-title":"Am J Roentgenol"},{"key":"1754_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10072-014-1627-6","volume":"35","author":"E Trevisan","year":"2014","unstructured":"Trevisan E, Bertero L, Bosa C et al (2014) Antiangiogenic therapy of brain tumors: the role of bevacizumab. Neurol Sci 35:507\u2013514","journal-title":"Neurol Sci"},{"issue":"1","key":"1754_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-010-0293-7","volume":"102","author":"MB Ellingson","year":"2011","unstructured":"Ellingson MB, Malkin MG, Rand SD et al (2011) Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant glioma. J Neurooncol 102(1):95\u2013103","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1754-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-1754-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-1754-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:22:48Z","timestamp":1559348568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-1754-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,11]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1754"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-1754-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,11]]}}}